Sigma Life Science, the innovative biological products and services brand of Sigma-Aldrich announced a significant expansion to its web-based biological research portal for exploring dynamic gene-based content, Your Favorite Gene Powered By Ingenuity. The latest version of Your Favorite Gene Powered By Ingenuity adds a biologically relevant literature search, gene regulation, and variation viewers, expression study results, clinical trials, detailed disease relationships, and biochemical compound interactions related to the researcher’s gene of interest.
These additions build upon the January 2009 release, which brought together Sigma-Aldrich’s leading Your Favorite Gene search engine and Ingenuity Systems’ Knowledge Base, the world’s largest repository of biological and chemical networks. The expansion complements the suite of dynamic biological pathways, interaction networks, and gene overviews containing up-to-date, manually curated findings from Ingenuity.
“We launched Your Favorite Gene Powered By Ingenuity to serve as a leading destination for researchers and students exploring diseases, functions and gene pathways,” said Dr. David Smoller, president of Sigma-Aldrich’s Research Biotech business unit. “This expansion allows us to bring the broadest collection of relevant biological information in one place and match it to our comprehensive portfolio of products, enabling researchers to quickly find the products they need to perform their experiments.”
“After a very successful initial launch, researchers told us that they wanted access to more information,” added Kyle Brueggeman, Sigma-Aldrich’s product manager for Your Favorite Gene Powered By Ingenuity. “We have responded to that need by adding not only content but also greater functionality that allows researchers to quickly connect with information that is directly relevant to their research.”
Your Favorite Gene Powered By Ingenuity provides researchers with the capability to model and evaluate prospective experiments in the context of previously published scientific literature, and provides streamlined access to Sigma-Aldrich’s extensive portfolio of validated shRNAs, siRNAs, Prestige Antibodies powered by Atlas antibodies, bioactive small molecules, CompoZr ZFNs, and induced pluripotent stem (iPS) cells. The portal is free for all researchers and students.
